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Comprehensive proteomics analyses of spliceosomal complexes are currently limited to those in humans,
and thus, it is unclear to what extent the spliceosome’s highly complex composition and compositional
dynamics are conserved among metazoans. Here we affinity purified Drosophila melanogaster spliceosomal B
and C complexes formed in Kc cell nuclear extract. Mass spectrometry revealed that their composition is highly
similar to that of human B and C complexes. Nonetheless, a number of Drosophila-specific proteins were
identified, suggesting that there may be novel factors contributing specifically to splicing in flies. Protein
recruitment and release events during the B-to-C transition were also very similar in both organisms. Electron
microscopy of Drosophila B complexes revealed a high degree of structural similarity with human B complexes,
indicating that higher-order interactions are also largely conserved. A comparison of Drosophila spliceosomes
formed on a short versus long intron revealed only small differences in protein composition but, nonetheless,
clear structural differences under the electron microscope. Finally, the characterization of affinity-purified
Drosophila mRNPs indicated that exon junction complex proteins are recruited in a splicing-dependent manner
during C complex formation. These studies provide insights into the evolutionarily conserved composition and
structure of the metazoan spliceosome, as well as its compositional dynamics during catalytic activation.
Pre-mRNA splicing is catalyzed by the spliceosome, a large
RNP molecular machine consisting of the U1, U2, U4/U6, and
U5 snRNPs plus a multitude of non-snRNP proteins (reviewed
in reference 59). Spliceosome assembly is an ordered, highly
dynamic process that leads to the stepwise formation of the
catalytic site(s) responsible for catalyzing the excision of an
intron of a pre-mRNA and ligation of its flanking exons (re-
viewed in reference 59). Initially, the U1 snRNP interacts with
the conserved 5 splice site (5 ss) of the pre-mRNA, forming
the spliceosomal E complex, and in the next step the U2
snRNP stably interacts with the pre-mRNA’s branch site, lead-
ing to the A complex (i.e., prespliceosome). The preformed
U4/U6.U5 tri-snRNP particle then interacts with the A com-
plex to generate the precatalytic B complex. The latter is con-
verted to the catalytically activated B* complex, a process
involving major RNP rearrangements, including destabiliza-
tion or loss of the U1 and U4 snRNPs. The first step of splicing
subsequently ensues and involves a nucleophilic attack of the
branch point adenosine at the 5 ss, generating a cleaved 5
exon and intron-3 exon lariat intermediate. The spliceosomal
C complex is formed at this time and subsequently catalyzes
the second step of splicing, which entails intron excision and
concomitant ligation of the 5 and 3 exons to form mRNA.
The mRNA, in the form of an RNP, is then exported to the
cytoplasm for translation by the ribosome.
During spliceosome assembly, a complex RNA-RNA net-
work involving the snRNAs and pre-mRNA is formed (re-
viewed in references 37 and 51). This RNA-RNA network
plays a central role in juxapositing the reactive groups of the
pre-mRNA (i.e., the 5 ss, 3 ss, and branch site). RNA struc-
tures involving U2 and U6 snRNA play crucial roles in the
catalytic core of the spliceosome, with nucleotides of U6 di-
rectly involved in the catalysis of pre-mRNA splicing (reviewed
in reference 55).
Proteins also play an essential role in splicing, both during
spliceosome assembly and the catalytic steps of splicing. Re-
cent analyses have demonstrated that the spliceosome is an
extremely protein-rich molecular machine (reviewed in refer-
ences 23 and 59). In humans, more than 50 proteins are re-
cruited to the spliceosome as stable components of the spli-
ceosomal snRNPs. In addition to these proteins, over 100
non-snRNP proteins are associated with human spliceosomes,
as determined by mass spectrometry (MS) of affinity-purified
spliceosomal complexes (11, 20, 22, 30, 31, 40, 61). MS studies
of human spliceosomal complexes isolated at defined assem-
bly/functional stages, including the A, B, and C complexes (3,
5, 11, 20, 22, 30, 31), further revealed that the spliceosome’s
protein composition is highly dynamic, with a major composi-
tional change occurring during the transition from the pre-
catalytic B complex to the catalytically active C complex. The
ability to isolate human spliceosomes has also led to major
advances in the elucidation of their structure. Higher-order
structures at a resolution of 30 to 40Å have been obtained for
affinity-purified human spliceosomal A, B, BU1 (i.e., B lack-
ing U1), and C complexes by using single-particle electron
microscopy (EM) (3, 7, 11, 24).
The spliceosome assembly pathway and catalytic mecha-
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nisms of pre-mRNA splicing are generally conserved among
higher and lower eukaryotes. Splice site and branch site con-
sensus sequences are also largely conserved among metazoans,
including Drosophila melanogaster and humans (29, 35, 48).
However, there are some differences between vertebrates and
Drosophila, including (i) a lower incidence in Drosophila of a G
nucleotide preceding the branched nucleotide in the branch
point sequence (BPS) and (ii) the absence of a polypyrimidine
tract between the BPS and 3 ss in many Drosophila introns
(35). Furthermore, in contrast to the situation in humans,
where more than 90% of introns are longer than 130 nucleo-
tides (nt), a large percentage (54%) of Drosophila introns are
less than 80 nt in length, with most having lengths from 59 to
67 nt (29, 35). Most of these “short” introns cannot be spliced
in mammals, where the minimum intron length required for
splicing is 80 nt (18, 58). In the case of long introns, splice
site pairing is thought to be first established across the exon
(so-called exon definition) and, at a later stage, cross-intron
interactions are established (4, 41). In contrast, the initial pair-
ing of the splice sites of short introns is thought to occur across
the intron (52).
Whereas biochemical approaches have been extensively
used to identify spliceosomal proteins in mammals, Drosophila
has been primarily used to study regulated splicing events by
using genetic approaches (reviewed in reference 6). Indeed, a
large percentage of Drosophila pre-mRNAs are subject to al-
ternative splicing (8), and several regulated splicing events in
Drosophila have been well characterized (reviewed in refer-
ences 14 and 39). With the completion of the sequence of the
Drosophila genome, bioinformatics approaches confirmed the
presence of D. melanogaster homologues of most human
snRNP proteins, as well as many non-snRNP spliceosome-
associated proteins (36). These proteins are generally highly
conserved and more closely related to their human, as opposed
to Saccharomyces cerevisiae yeast, counterparts (36). Biochem-
ical/genetic approaches have also identified Drosophila ortho-
logues of a subset of human splicing factors. However, to date,
Drosophila spliceosomes have not been affinity purified, nor
has their protein composition been determined. Thus, it is not
clear to what extent the protein compositions of human and fly
spliceosomes are conserved. Likewise, it is not known whether
the exchange of proteins, particularly during catalytic activa-
tion of the spliceosome, is conserved between these two evo-
lutionarily distant organisms. MS analyses of spliceosomes
from Drosophila melanogaster might provide insights into the
“core proteome” of the metazoan spliceosome.
During splicing, the mRNA is bound by several proteins that
affect its subsequent metabolism, including its export from the
nucleus, its localization in the cytoplasm, the efficiency of its
translation in the cytoplasm, and its susceptibility to nonsense-
mediated decay (NMD) (reviewed in reference 34). In verte-
brates, a multiprotein complex, termed the exon junction com-
plex (EJC), associates with the mRNA in a splicing-dependent
but sequence-unspecific manner approximately 20 to 24 nt
upstream of the exon-exon junction, protecting this region
against RNase H cleavage (28). The EJC consists of four stably
associated core proteins, eIF4AIII, MLN51, Magoh, and Y14,
plus a number of factors that bind transiently or less stably (53,
54). D. melanogaster homologues of the main components of
the human EJC have been identified, and several factors have
been studied extensively (16, 19, 38, 49). However, it is not
known in the fruit fly whether an EJC is deposited onto the
mRNA as a consequence of pre-mRNA splicing.
To learn more about the evolutionarily conserved composi-
tion of the spliceosome, as well as the dynamics of spliceo-
somal protein recruitment/release, we have affinity purified
Drosophila spliceosomal B and C complexes assembled in Kc
cell nuclear extract and determined their composition by using
MS. For comparative purposes, we also isolated B complexes
formed on an identical substrate (the fushi tarazu pre-mRNA)
in HeLa nuclear extract. These studies revealed a remarkable
conservation of spliceosome-associated proteins in two evolu-
tionarily distant organisms but also identified apparent Dro-
sophila-specific splicing factors. Negative-stain EM revealed
that the two-dimensional (2D) structure of the Drosophila B
complex is also highly similar to that of the human B complex,
consistent with a conservation of higher-order interactions
within both spliceosomes. We also isolated spliceosomal B
complexes formed on a short Drosophila intron (Zeste62) and
show that although their protein composition differs only min-
imally from Ftz B complexes, structural differences are ob-
served under the electron microscope. A comparison of Dro-
sophila B and C complexes further revealed that the
recruitment and release of factors during the conversion of the
catalytically inactive B complex to the catalytically active C
complex is also largely conserved between humans and flies.
Lastly, we affinity purified spliced and unspliced mRNPs from
Drosophila Kc cell nuclear extract and determined their pro-
tein composition by MS. These studies revealed that, as in
humans, components of the EJC are deposited onto the
mRNA in a splicing-dependent manner.
MATERIALS AND METHODS
Construction of plasmids and in vitro transcription. PCR products containing
a fragment of the D. melanogaster fushi tarazu gene consisting of either exon 1,
intron 2, and exon 2 (Ftz) or solely exon 1 and exon 2 (FtzI) plus three MS2
RNA aptamers at their 3 end were generated by PCR-based techniques and
used as templates for the transcription of Ftz-M3 pre-mRNA or Ftz-M3 mRNA,
respectively. Ftz pre-mRNA lacking a 3 ss and 3 exon but containing an
elongated (29 nt) polypyrimidine tract was generated from the wild-type Ftz
pre-mRNA template (pFtz-M3) by PCR-based techniques. The resulting PCR
product was then cloned into a plasmid (pUC18-MS2) downstream of three MS2
RNA aptamers, generating pM3-Ftz-longPYT. A fragment of the D. melanogaster
Zeste gene, comprising part of exon 2, the 62-nt-long intron 2, and a portion of exon
3, was amplified from genomic DNA by PCR using the primers 5GGGGTACCA
ATGATCTGCTGCACTTCAAGACAG-3 (ZesteForKpn1) and 5-CGGGATCC
GGCGGTAATTGTGGCCATTGG-3 (ZesteRevBamH1). The resulting PCR
product was then cloned into pUC18-MS2 upstream of three MS2 RNA aptamers,
generating pZeste62-M3. Uniformly 32P-labeled m7G(5)ppp(5)G-capped pre-
mRNAs were synthesized in vitro by T7 runoff transcription in the presence of
[32P]UTP (GE Healthcare).
In vitro splicing. Drosophila Kc cells were cultivated in suspension at room
temperature in EX-Cell 420 serum-free medium for insect cells. Kc cell and
HeLa nuclear extract were prepared essentially according to the method in
reference 12. In vitro splicing reactions contained 40% Kc cell or HeLa nuclear
extract in buffer D (20 mM HEPES-KOH, pH 7.9, 20% [vol/vol] glycerol, 100
mM KCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM dithioerythritol, 0.5 mM
phenylmethylsulfonyl fluoride, and in the case of Kc cells, 0.05% NP-40), 5 mM
ATP, 20 mM creatine phosphate, and 4.5 to 7.5 nM of 32P-labeled pre-mRNA or
mRNA (specific activity, 100 dpm/fmol). The final concentration of MgCl2 was
adjusted to 4 mM (Kc) or 3 mM (HeLa), and HEPES-KOH (pH 7.9) was
adjusted to 22 mM in both cases. Splicing reaction mixtures were incubated at
22°C (Kc) or 30°C (HeLa). For analysis of splicing, RNA was recovered and
separated on an 8 M urea–12% polyacrylamide gel and detected by autoradiog-
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raphy. Spliceosomal complexes were analyzed on native 3.5% polyacrylamide
gels essentially as previously described (27).
MS2 affinity purification. Recombinant MBP-MS2 fusion protein was ex-
pressed in Escherichia coli and purified essentially as described previously (22).
To isolate spliceosomal complexes or mRNPs, pre-mRNA or mRNA was incu-
bated with a 20-fold molar excess of purified MBP-MS2 fusion protein for 30 min
on ice prior to addition to the splicing reaction mixture. To isolate B complexes,
Ftz-M3 or Zeste62-M3 pre-mRNA was incubated in Kc nuclear extract for 8 or
20 min, respectively, or Ftz-M3 was incubated in HeLa nuclear extract for 6 min
under splicing conditions. To isolate C complexes or mRNPs, pre-mRNA or
mRNA was incubated for 180 min in Kc nuclear extract under splicing condi-
tions. To isolate C complexes, two DNA oligonucleotides complementary to the
Ftz 5 exon (at nt 6 to 17 [5-TCGATGTGCGAC-3] and nt 18 to 30
[5-GCCAAAGTCTCC-3] relative to the 5 ss) or, to isolate mRNPs, DNA
oligonucleotides complementary to intronic sequences of Ftz-M3 pre-mRNA
(5-GTTGTTAATCGTGTGT-3 and 5-GTAAGCATAAGCAAAG-3) were
added subsequently at a 100-fold molar excess, and the reaction mixture was
incubated for an additional 20 min at 22°C to allow cleavage by RNase H present
in the extract. In vitro splicing reaction mixtures were then loaded onto linear
10-to-30% (vol/vol) glycerol gradients containing GP150 buffer (20 mM HEPES-
KOH, pH 7.9, 150 mM NaCl, 1.5 mM MgCl2). The gradients were centrifuged at
23,400 rpm in a Surespin 630 rotor (Sorvall) for 15 h 45 min at 4°C and harvested
manually in 1.5-ml fractions from the top. The peak fractions containing B/C
complexes or mRNPs were determined by Cherenkov counting and then pooled
prior to being applied to an amylose-Sepharose column. After being washed with
40 column volumes of GP150 buffer, bound complexes were eluted with GP150
buffer containing 15 mM maltose. RNA and protein of the eluates were recov-
ered and analyzed by denaturing polyacrylamide gel electrophoresis (PAGE) or
sodium dodecyl sulfate-PAGE, respectively. RNA was visualized by silver stain-
ing or autoradiography and protein by staining with Coomassie blue. The stoi-
chiometry of the snRNAs and pre-mRNA/splicing intermediates was determined
by visual inspection of the silver-stained bands, taking into consideration the
length of the individual RNAs.
MS and BLAST searches. To identify proteins by MS, proteins were separated
by one-dimensional (1D) PAGE (4 to 12% NuPAGE bis-Tris; Invitrogen) and
entire lanes of the Coomassie-stained gels were cut into 25 slices of equal
dimensions, irrespective of the visual presence or absence of a protein band. MS
was performed after digestion of proteins in-gel, and peptides were analyzed on
a liquid chromatography (LC)-coupled electrospray ionization quadropole time-
of-flight (Q-Tof; Waters) mass spectrometer and/or a linear ion trap (4000
QTrap; Applied Biosystems) mass spectrometer as previously described (11).
Human homologues of the identified Drosophila proteins (or vice versa) were
identified by performing BLAST searches using the NCBI server.
EM. For EM, eluted complexes were fixed by being loaded onto a 4.4-ml,
linear 10-to-30% glycerol gradient containing 0.1% gluteraldehyde in the 30%
gradient solution (26) and centrifuged for 107 min at 60,000 rpm (374,000  g).
Gradients were subsequently fractionated from the bottom by using a fraction
collector. Particles were negatively stained by the double-carbon-film method
(25). Images were recorded with a calibrated CM120 EM (FEI, Eindhoven, The
Netherlands) at a magnification of 88,000 or 115,000 in eucentric height at a
defocus of approximately 1.5 m. The microscope was equipped with a TemCam
F224A digital camera (TVIPS, Gauting, Germany). Following a reference-free
alignment (13), images were subjected to multivariate statistical analysis and
classification (13, 56, 57). The resulting 2D class averages were in turn used as a
reference during subsequent rounds of alignment until stable classes were
achieved.
RESULTS
Kinetics of splicing of Ftz-M3 pre-mRNA in Kc and HeLa
nuclear extract. To isolate Drosophila melanogaster spliceo-
somal complexes, the fushi tarazu (Ftz) pre-mRNA substrate,
which is derived from the naturally occurring Drosophila fushi
tarazu gene and was shown previously to be spliced efficiently
in both HeLa (43) and Drosophila nuclear extract (45), was
used. For MS2 affinity purification, three MS2 binding sites
were added to the 3 end, generating Ftz-M3 pre-mRNA (Fig.
1A). In vitro splicing was performed for 0 to 180 min with
nuclear extract prepared from Drosophila melanogaster Kc cells
or HeLa cells and in vitro-transcribed 32P-labeled Ftz-M3 pre-
mRNA. RNA was recovered and analyzed on a denaturing
polyacrylamide gel. Splicing intermediates were first observed
after 10 min and 8 min in Kc and HeLa nuclear extract, re-
spectively, whereas splicing products were visible after 12 min
(Kc) and 10 min (HeLa) (Fig. 1B; see Fig. S1A in the supple-
mental material). As determined by native gel electrophoresis,
spliceosomal B and C complexes were formed in Kc nuclear
extract after 4 min and 12 min of incubation, respectively (Fig.
1C, lanes 4 and 8). Similar kinetics of splicing complex forma-
tion (4 min and 10 min for B and C, respectively) were ob-
served with HeLa nuclear extract (see Fig. S1B in the supple-
mental material). To isolate B complexes with little or no C
complex contamination, splicing was thus performed for 8 min
in Kc nuclear extract and for 6 min in HeLa nuclear extract.
Isolation of spliceosomal B complexes assembled on MS2-
tagged Ftz pre-mRNA in Kc or HeLa nuclear extract. For the
preparative isolation of human and Drosophila B complexes,
the Ftz-M3 substrate was first incubated with MS2-MBP fusion
protein prior to its addition to a splicing reaction mixture.
Spliceosomes were then allowed to form for 8 (Kc) or 6
(HeLa) min, and the splicing reaction mixture was subse-
quently subjected to glycerol gradient centrifugation in order
to separate B complexes from other spliceosomal complexes
(such as the A complex) and also from excess MS2-MBP pro-
tein. The distribution of spliceosomal complexes in the gradi-
ent was determined by measuring the amount of radiolabeled
RNA in each fraction. As shown in Fig. 2A, two main peaks are
apparent, one in fractions 9 to 13 (Drosophila) or 11 to 15
(human) which corresponds mainly to a mixture of A and H
complexes and a second peak in fractions 17 to 19 which corre-
sponds to the B complex. Thus, Drosophila and human spliceo-
somal B complexes exhibit very similar sedimentation coefficients,
with complexes from both species migrating in the 40S to 45S
region of the gradient. In contrast, human H and/or A complexes
exhibit a slightly higher sedimentation coefficient (25S) than
their Drosophila melanogaster counterparts (20S).
Fractions 17 to 19, i.e., the peak fractions containing B
complexes, were pooled and applied to amylose-coated Sepha-
rose beads. After extensive washing, spliceosomes were eluted
under native conditions with an excess of maltose, and their
RNA and protein were subsequently analyzed by denaturing
PAGE. The eluate of both Drosophila and human Ftz-M3
complexes contained nearly equimolar amounts of uncleaved
pre-mRNA, as well as U1, U2, U4, U5, and U6 snRNA (Fig.
2B, upper panel, lanes 3 and 6), consistent with their designa-
tion as B complexes. The near-stoichiometric levels of U4 and
U1 indicate that predominantly B and not activated B* com-
plexes were isolated. Only small amounts of intron-lariat (5 to
6% as quantitated by phosphorimager analysis) but no splicing
products were detected after autoradiography (Fig. 2B, lower
panel, lanes 3 and 6). Thus, precatalytic spliceosomal B com-
plexes of high purity (as judged by the absence of contaminat-
ing RNAs), with only minor amounts of contaminating B* and
C complex, could be purified from Kc and HeLa cell nuclear
extract.
Protein composition of affinity-purified Drosophila and hu-
man B complexes formed on Ftz pre-mRNA. Proteins isolated
from affinity-purified Drosophila and human B complexes were
separated by 1D PAGE and visualized by Coomassie staining.
Proteins were subsequently identified by LC-tandem MS (MS-
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MS) and scored by the absolute number of peptides found in
each preparation. The protein composition of precatalytic spli-
ceosomal B complexes formed in Kc and HeLa extract was
determined in two independent experiments and is summa-
rized in Table 1. Only proteins detected reproducibly by MS
(i.e., in two out of two preparations) are shown in Table 1;
proteins detected in only one preparation (see Table S1 in the
supplemental material) are more likely to be contaminants and
are therefore not included. The human homologue of the iden-
tified Drosophila protein (or vice versa) was determined by
BLAST searches, and for simplicity’s sake we use the name of
the human homologue of a given Drosophila protein.
More than 120 proteins were identified reproducibly in Dro-
sophila and human B complexes assembled on MS2-tagged Ftz
pre-mRNA (Table 1). Most proteins identified in Drosophila B
complexes were also found in human B complexes. The pro-
teins common to Drosophila and human B complexes included
nearly all U1, U2, U4/U6, and U5 snRNP-associated proteins.
A large number of non-snRNP proteins were also shared by
Drosophila and human Ftz B complexes. For example, several
FIG. 1. Kinetics of splicing and splicing complex formation with Fushi tarazu (Ftz) and Zeste62 pre-mRNA. (A and D) Schematic represen-
tations of the Ftz-M3 and Zeste62-M3 pre-mRNA substrates. PY tract, polypyrimidine tract; nts, nucleotides. (B, C, E, and F) Splicing was
performed with Ftz-M3 pre-mRNA (B and C) or Zeste62-M3 pre-mRNA (E and F) in Kc cell nuclear extract for the times indicated (in minutes)
above each lane. In the experiments whose results are shown in panels B and E, RNA was recovered, analyzed on a 12% polyacrylamide–8 M urea
gel, and visualized by autoradiography. Splicing substrates, intermediates, and products are indicated on the right. *, the band likely corresponds
to debranched, spliced-out intron. Panels C and F show results for splicing complexes analyzed on a 3.5% native polyacrylamide gel and visualized
by autoradiography. The positions of the H, A, B, and C complexes are indicated on the right.
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members of the SR protein family were identified in both,
including SF2/ASF and SRp55. Nearly all components of the
Prp19/CDC5 complex could be identified in both Drosophila
and human B complexes. With the exception of Cyp-E (the
latter was detected solely in Drosophila Ftz complexes), essen-
tially all proteins designated Prp19/CDC5 related were also
present in both. A number of non-snRNP proteins previously
detected in purified human A and/or B complexes were also
shared by both human and Drosophila Ftz B complexes. In
contrast, most proteins required for the first or second step of
FIG. 2. MS2 affinity selection of spliceosomal B complexes. (A) Splicing reaction mixtures containing Ftz-M3 pre-mRNA and Kc or HeLa
nuclear extract or Zeste62-M3 pre-mRNA and Kc nuclear extract were subjected to glycerol gradient centrifugation. The radioactivity contained
in each gradient fraction was determined by Cherenkov counting and expressed as the percentage of the total 32P-RNA loaded onto the gradient.
Sedimentation coefficients (indicated by arrowheads) were determined by analyzing the UV absorbance of fractions of a reference gradient
containing prokaryotic ribosomal subunits. (B) Gradient fractions 17 to 19 containing Ftz B complexes formed in Kc (lanes 1 to 3) or HeLa (lanes
4 to 6) extract or Zeste62-M3 B complexes formed in Kc extract (lanes 7 to 9) were pooled and subjected to MS2 affinity selection. Bound
complexes were eluted with maltose, and RNA was recovered, separated by denaturing PAGE, and visualized by silver staining (upper panel) or
by autoradiography (lower panel). Lanes 1, 4, and 7, 2% of the input (I) pooled gradient fractions. Lanes 2, 5, and 8, 2% of the flowthrough (FT)
of the amylose column. Lanes 3, 6, and 9, 25% of the eluted (E) spliceosomal complexes. The positions of the snRNAs, unspliced pre-mRNA, and
splicing products/intermediates are indicated on the right.
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TABLE 1. Protein composition of Drosophila spliceosomal B and C complexesa
Human proteinb GenBankaccession no.
Drosophila melanogaster protein
Presence of or absolute no. of peptides sequenced for proteinc
in indicated complex in:
HeLa nuclear


















1 2 1 2 1 2 3 1 2
Sm proteins
B gi17136806 CG5352 SmB 21.0 ● 10 12 22 11 11 12 12 12 11 ●
D1 gi17864386 CG10753 snRNP69D 13.8 ● 7 9 3 2 4 5 4 4 5 ●
D2 gi21357623 CG1249 SmD2 13.5 ● 17 17 19 10 18 16 10 14 12 ●
D3 gi24652901 CG8427 SmD3 15.6 ● 9 15 18 11 17 11 15 7 4 ●
E gi24582631 CG18591 11.1 ● 9 5 5 8 11 6 9 8 6 ●
F gi22024001 CG16792 DebB 9.7 ● 11 13 5 2 2 ●
G gi29428065 CG9742 12.7 ● 2 3 6 3 4 3 4 3 3 ●
U1 snRNP
U1-70K gi17137278 CG8749 U1-70K 52.9 ● 1 4 17 5 5 7 6 1
U1-A gi17737284 CG4528 snf 24.6 ● 12 4 4 2 4 5 5
U1-associated
S164/RBM25 gi18857955 CG4119 112.7 1 1 18 7 11 13 12
FBP11 gi24581324 CG3542 91.3 9 6 8 13 11
U2 snRNP
U2A gi19921760 CG1406 U2A 29.7 ● 18 20 9 2 9 8 9 8 5 ●
U2B	 gi17737284 CG4528 snf 24.6 ● 5 7 12 4 4 2 5 5 ●
SF3a120 gi24647566 CG16941 88.1 ● 26 32 84 21 28 26 20 20 9 ●
SF3a66 gi24663500 CG10754 30.3 ● 2 5 4 3 6 5 4 2 ●
SF3a60 gi17137118 CG2925 noi 58.4 ● 14 19 28 16 15 15 17 9 3 ●
SF3b155 gi45550087 CG2807 149.6 ● 37 54 102 29 48 49 54 15 16 ●
SF3b145 gi19920622 CG3605 84.8 ● 20 30 25 13 17 22 13 10 9 ●
SF3b130 gi24654874 CG13900 136.6 ● 50 71 66 36 68 50 60 28 30 ●
SF3b49 gi17530817 CG3780 spx 39.7 ● 1 2 1 ●
SF3b14a/p14 gi21357707 CG13298 14.2 ● 14 6 7 8 8 6 6 5 6 ●
SF3b14b gi24582237 CG9548 12.5 ● 6 9 3 5 6 5 4 3 ●
SF3b10 gi24645240 CG11985 10.0 ● 1 2 4 1
U2-related
hPRP43 gi19921728 CG11107 82.7 ● 7 11 3 2 8 3 3 4 ●
SPF45 gi116007460 CG17540 44.4 ● 3 1
SPF30 gi16769358 CG17454 SPF30 28.2 ● 2 2 4 2 7 7 5
U2AF65 gi17136764 CG9998 U2af50 46.7 ● 6 2 8 7 9 11 8
U2AF35 gi17137284 CG3582 U2af38 29.9 ● 2 4 1 3 2
PUF60 gi24655242 CG12085 pUf68 67.9 3 20 9 25 17 16 29 12
A proteins
RBM10 gi24580815 CG4887 114.2 ● 1 1
SF1 gi24647704 CG5836 SF1 87.4 3 1 1 1
A/B proteins
DDX9 gi62474635 CG11680 mle 143.7 ● 24 33
ZC3H18/LOC124245 gi24640344 CG1677 109.1 ● 10 12 23 9 12 9 12 3 ●
ASR2B gi24585960 CG7843 107.2 ● 15 23 50 18 24 22 29 8 ●
TCERG1 (CA150) gi116007968 CG33097 84.8 ● 1 5 14 2 2 1 3 2
p68/DDX5 or DDX17 gi45551833 CG10279 Rm62 78.5 ● 4 19 10 18 14 19 15 14 ●
ELAV (HuR) gi62471589 CG3151 Rbp9 70.5 ● 1 4 ●
RBM39/RNPC2 gi45550943 CG11266 66.5 ● 7 6 20 16 14 23 4 1 ●
NF45/ILF2 gi21357109 CG5641 43.7 ● 15 31 23 6 3 2 1 1 ●
YBX-1 gi24663131 CG5654 yps 38.9 ● 16 15 11 4 4 3 6 2 9 ●
TLS/FUS gi24642436 CG3606 caz 38.8 ● 3 6
HCNGP gi19921898 CG2063 36.2 1 1 1
SR proteins
SFRS12 gi17137528 CG4602 Srp54 58.5 10 2 7 5 3 13 7
SRp55 gi28571701 CG10851 B52 42.8 ● 2 1 8 3 8 10 6 9 3 ●
Continued on following page
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Drosophila melanogaster protein
Presence of or absolute no. of peptides sequenced for proteinc
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HeLa nuclear


















1 2 1 2 1 2 3 1 2
hTra-2 b/SFRS10 gi45552623 CG10128 Tra2 31.0 ● 3 3 2 ●
SF2/ASF gi21358097 CG6987 SF2 28.4 ● 4 15 4 9 12 8 6 8 7 ●
9G8 gi24582360 CG10203 xl6 27.9 ● 7 15 1 1 2 3 ●
SRp20 gi24641772 CG1987 Rbp1-like 16.8 1 2 1 ●
SRp30c Œe ● 1 5 ●
SRp38 Œ ● 3 8 ●
SR-related
SRm300 gi161080550 CG7971 127.3 9 13 19 3 3 1 41 19 ●
SRm160 gi24663664 CG11274 SRm160 107.6 ● 3 1 1 3 2 ●
Cap binding complex
CBP80 gi24639721 CG7035 Cbp80 93.2 ● 25 35 37 9 21 24 21 13 8 ●
CBP20 gi17738031 CG12357 Cbp20 17.7 ● 11 11 7 1 2 2 2 4 1 ●
hnRNP
hnRNP A0 ● 3 4
hnRNP A1 —f ● 11 16 ●
hnRNP A3 — ● 4 8 ●
hnRNP AB — ● 4 7
hnRNP A2/B1 — ● 10 23
hnRNP C — ● 22 49 ●
hnRNP D — 4 4 ●
hnRNP G — ● 13 11 ●
hnRNP K — 1 3
hnRNP L — 27 46
hnRNP Q — ● 13 23 ●
hnRNP R — ● 44 41 ●
hnRNP U — 4 6 ●
hnRPUL2/SAF-A2 — 4 2
PCBP1 — ● 3 7 ●
RALY — ● 5 8 ●
— gi22024201 CG30122 81.0 1 2
— gi161078453 CG17838 76.9 8 1 2 7 6
— gi24646609 CG16901 sqd 63.2 2 5
— gi11040 hrp40.2 39.5 2 2
U5
220K gi20129897 CG8877 prp8 279.4 ● 92 140 149 71 123 150 161 202 104 ●
200K gi28574898 CG5931 244.5 ● 86 120 134 54 136 99 113 171 108 ●
116K gi21357743 CG4849 110.7 ● 33 46 61 42 41 34 46 90 43 ●
102K gi24666532 CG6841 105.2 ● 30 75 44 21 30 21 26 6 3 ●
100K gi24584994 CG10333 94.6 ● 26 27 26 19 23 21 18 3 2 ●
52K gi24583433 CG5198 LIN1 36.8 ● 2 5
40K gi24580577 CG3436 38.9 ● 16 10 23 7 6 9 10 24 17 ●
15K gi28574029 CG3058 16.8 ● 3 8 4 3 3 5 4
LSm proteins
LSm2 gi21358381 CG10418 10.7 ● 9 6 5 2 2 7 5 1 ●
LSm3 gi24649486 CG5926 11.9 ● 2 4 2 2 ●
LSm4 gi78706862 CG17764 30.6 ● 2 6 7 2 1 3
LSm5j gi21358059 CG6610 10.1
LSm6j gi24656550 CG9344 9.0 ● ●
LSm7 gi20129565 CG13277 12.2 ● 2 3 3 2 3 3 4 2 2 ●
LSm8 gi24655606 CG2021 10.4 ● 4 1 1 ●
U4/U6 snRNP
90K gi24667067 CG7757 67.4 ● 27 34 41 15 12 17 15 ●
60K gi21355245 CG6322 61.6 ● 16 25 22 16 13 22 24 2 ●
61K gi21357435 CG6876 55.5 ● 15 17 42 27 15 22 22 ●
Continued on following page
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Drosophila melanogaster protein
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HeLa nuclear


















1 2 1 2 1 2 3 1 2
20K gi24586038 CG17266 20.2 ● 10 12 11 8 10 6 3 ●
15.5K gi17864298 CG3949 hoi-polloi 13.8 ● 3 1 3 3 2 3 3 ●
U4/U6.U5
110K gi24583764 CG6686 112.6 ● 37 31 19 12 12 12 11 ●
65K gi18859907 CG7288 57.5 ● 11 18 20 9 14 16 16 ●
27K gi19922846 CG18426 ytr 21.5 2 5 10 6 4 3
TFIP11 gi24582006 CG7238 sip1 94.8 ● 2 4 6 3 5 4 4 1 ●
hPRP38 gi22024089 CG30342 40.1 ● 13 10 19 7 7 11 8 7 6 ●
hPRP19/CDC5L
CDC5L gi19922992 CG6905 cdc5-like 93.1 ● 18 20 21 7 24 19 16 46 28 ●
Hsp73 (CCAP1) gi28571721 CG4264 Hsc70-4 71.1 ● 4 5 2 3 3 ●
hPRP19 gi17647459 CG5519 Gbp 55.2 ● 15 24 37 18 22 21 16 49 44 ●
PRL1 gi18859793 CG1796 Tango4 52.7 ● 9 13 8 5 4 7 14 29 19 ●
SPF27 gi24650745 CG4980 31.3 ● 6 4 11 2 5 7 5 11 17 ●
AD002 (CCAP2) gi21358119 CG12135 c12.1 28.4 ● 2 3 3 2 8 13 ●
Npw38BP gi20128957 CG2685 61.0 ● 9 10 6 2 1
Npw38 gi21356239 CG11820 27.1 ● 2 5 2 2 2 1 1
hPRP19/CDC5L related
KIAA0560 gi45553341 CG31368 172.0 ● 11 7 63 6 24 30 35 102 65 ●
hSYF1 (XAB2) gi20129961 CG6197 103.3 ● 13 4 13 1 11 13 11 39 36 ●
CRNKL1/Clf1 gi17137126 CG3193 crn 84.3 ● 14 12 17 1 16 17 29 62 40 ●
SKIP gi24640727 CG8264 BX42 61.2 ● 13 12 19 6 3 7 8 40 28 ●
hECM2 (fSAP47) gi28573264 CG14641 47.2 ● 5 6 22 2 3 3 4 29 17 ●
Cyp-E gi17647301 CG4886 cyp33 33.3 ● 5 3 7 6 6 20 21 ●
hIsy1 gi78709073 CG9667 31.4 ● 3 2 2 6 4 8 13 12 ●
PPIL1 gi17986117 CG13892 Cypl 19.5 ● 3 4 7 2 6 6 2 11 7 ●
G10 gi17737310 CG1639 l(1)10Bb 17.0 ● 9 8 5 2 5 6 7 12 9 ●
RES complex
MGC13125 gi21355513 CG13625 76.5 ● 7 3 2 2 ●
SNIP1 gi62862214 CG17168 49.8 ● 4 5 ●
CGI-79 gi20129641 CG10466 17.8 ● 4 1 1 1 ●
B/B* proteins
hPRP4-kinase/PRPF4B gi19922978 CG7028 104.0 ● 7 10 18 4 5 10 6 2 ●
hPRP2 gi19921526 CG10689 102.8 ● 3 8 7 6 5 5 7 ●
PPIL4 gi21355677 CG5808 75.5 ● 2 1 1 1 1
RED gi21355769 CG18005 61.4 ● 10 8 17 3 9 5 9 9 1 ●
PPIL2/Cyp-60 gi19922376 CG7747 59.0 ● 7 5 1 ●
hSmu-1 gi21356791 CG5451 57.3 ● 20 22 16 8 7 7 14 12 4 ●
MFAP1 gi21358323 CG1017 56.1 ● 7 6 5 1 2 2 4 ●
FBP21 gi24580725 CG4291 38.8 ● 2 2 6 7 9 3
UBL5 gi24586084 CG3450 ubl 8.6 ● 3 4
C proteins
hPRP22 gi20129977 CG8241 pea 142.0 2 3 2 5 54 28 ●
PPIG, SR-Cyp gi28571910 CG1866 Moca-cyp 116.4 1 1 2 1 2 12 2 ●
Q9BRR8 gi24663949 CG8833 GPTC1 107.9 1 1 6 4 ●
cactin (c19orf29) gi45549144 CG1676 cactin 91.3 17 10 ●
DDX35 gi19920696 CG3225 76.1 3 3 2 3 12 8 ●
Abstrakt gi17977678 CG14637 abs 69.5 ● 1 3 4 42 17 ●
hPRP17 gi21355805 CG6015 65.4 ● 5 2 17 2 6 11 15 35 18 ●
GCIP p29 gi24652559 CG12343 26.5 ● 1 4 4 2 18 14 ●
EJC/mRNP
eIF4AIII gi24645031 CG7483 eIF4AIII 45.6 3 12 3 4 7 8 21 16 ●
Y14 gi24651979 CG8781 tsu 19.0 3 1 ●
Continued on following page
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1 2 1 2 1 2 3 1 2
Magoh gi17136332 CG9401 mago 17.3 ● 1 1 2 2 ●
Acinus gi24585110 CG10473 hkl 83.7 3 1 2 ●
UAP56 gi24581956 CG7269 Hel25E 48.7 ● 2 5 ●
Pinin gi161078140 CG8383 Pnn 35.9 1 2 1 ●
Aly/REF (THOC4) gi21356157 CG1101 Aly 27.9 1 2 1 1 ●
SAP18 gi17738001 CG6046 bin1 17.3 3 2 1 ●




SKIV2L2 gi17864608 CG4152 lethal(2)35Df 118.9 2 5 6 1 ●
GCFC gi24644714 CG1965 102.6 ● 2 3 1 7 6 8 3 3 ●
ZFR2 gi28574893 CG5215 Zn72D 96.0 12 16 21 8 2 1 1
RBM15B gi24586450 CG2910 nito 89.1 2 3 1 5 7
PABP gi45552715 CG5119 PABP 69.9 ● 2 6 14 12 13 13 22 15 10 ●
HsKin17 gi24667403 CG5649 kin17 45.4 ● 2 3 1 1 ●
RACK1 (GNB2L1) gi17137396 CG7111 RACK1 35.6 1 1 1 1 2 1 2 3 ●
RBM42 gi21357051 CG2931 33.6 1 2 17 8 7 8 8 1 ●
Novelh
IGF2BP1 gi116007146 CG1691 IMP-1 63.4 10 12 40 18 10 18 20 10 4




PSF gi62473776 CG4211 Bj6 82.0 8 2 9 8 7 8 2
NY-CO-10 gi21357249 CG10907 56.6 ● 1 4 1 2 1 3 2 ●
DGCR14 gi18858195 CG1474 ES2 56.0 12 6 ●
NKAP gi24650530 CG6066 52.9 8 2 ●
RBM4 gi24659981 CG8597 lark 39.9 ● 25 14 9 11 6 5 2
CDK10, PISSLRE gi24652305 CG1362 cdc2rk 39.4 1 2 2 ●
NOSIP gi24643007 CG6179 NOSIPL 34.2 3 1 ●
MORG1 gi24584567 CG4935 34.1 2 2 3 7 3 ●
CXorf56 gi20129505 CG16865 27.7 4 4 ●
Novelh
CDC27 gi24659892 CG8610 Cdc27 101.3 2 11 7 8
PIWIL1 gi161076864 CG6137 aub 98.6 7 2 1 2 2 3
APTX gi24648185 CG5316 76.5 8 3 2 1
MTHFSD gi161078016 CG14648 growl 58.8 20 3 10 7 9 10 2
LUC7-like gi24665973 CG7564 48.4 3 2 2 5 4
KHDRBS2 gi24658086 CG3613 QKR58E-1 42.3 4 1 3 2 2 1 1
PSME3 gi18860055 CG1591 REG 28.1 1 1 1 1 1
NH gi45553181 CG6143 pep 78.1 4 1 6 9 6 2
NH gi45550712 CG9684 71.9 78 42 8 12 6 1
NH gi24656457 CG8994 exu 58.0 1 3 3 2
NH gi24641752 CG15747 44.7 2 1 1 3
NH gi19922308 CG11808 25.7 3 1 2
Miscellaneous Drosophila
Ftz-M3 only, novelh
EIF2AK4 gi17137328 CG1609 Gcn2 178.5 1 1 1
G3BP2 gi24646611 CG9412 rin 75.0 4 2 1 1
ƒi gi24649433 CG13597 59.2 2 1
PRPF38B gi24641727 CG1622 45.4 1 1
NH gi28571193 CG5877 114.2 2 1
Continued on following page
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splicing (except Prp17) and most components of the EJC and
TREX complexes were absent or not consistently identified.
These data indicate that both human and Drosophila Ftz B
complexes are largely devoid of any contaminating C com-
plexes. Taken together, our results demonstrate that Drosoph-
ila homologues of the majority of proteins found in human
spliceosomes are also present in Drosophila spliceosomes.
Despite similarities in their compositions, some notable dif-
ferences also exist. Human B complexes contain a few proteins
not found in their Drosophila counterparts, including, among
others, the DEAD box protein DDX9, ELAV, components of
the RES (retention and splicing) complex, and the mRNP/
EJC-associated proteins Aly/REF, UAP56, and ELG (Table
1). Differences between Drosophila and human B complexes
formed on Ftz-M3 pre-mRNA are also seen in the subset of
SR proteins that are detected. Whereas SFRS12 was exclu-
sively present in Drosophila B complexes, 9G8, SRp38, and
SRp30c appear to be specifically associated with human Ftz B
complexes. The extensive homology between members of the
hnRNP protein family does not allow a conclusive assignment
of Drosophila homologues on the basis of data from BLAST
searches. Nonetheless, it is clear that the Drosophila B complex
contains significantly fewer proteins of the hnRNP protein
family, despite the fact that the hnRNP protein family in Dro-
sophila appears to be nearly as complex as that in humans (32).
Only the hnRNP protein CG17838 was consistently found in
purified Drosophila Ftz B complexes, in comparison with over
15 different hnRNP proteins in human complexes. This indi-
TABLE 1—Continued
Human proteinb GenBankaccession no.
Drosophila melanogaster protein
Presence of or absolute no. of peptides sequenced for proteinc
in indicated complex in:
HeLa nuclear


















1 2 1 2 1 2 3 1 2
NH gi24653446 CG6209 mst101(2) 69.0 1 4 9
NH gi24650092 CG12250 16.5 4 3 5
Miscellaneous Drosophila
Zeste62-M3 only
Spliceosomalg: AGGF1 gi24653802 CG8079 66.9 1 1
Novelh
SLC7A2 gi116007820 CG7255 85.6 1 1
NCOA5 gi17647723 CG8614 Neos 42.6 1 2 2
DNAJC17 gi24645889 CG17187 34.7 2 3
TFIIB gi19921082 CG5343 23.3 4 3 1
Miscellaneous HeLa only
Spliceosomalg
GEMIN3/DDX20 gi17647335 CG6539 Dhh1 116.5 1 1
SON3 gi24645429 CG8273 88.6 2 2
GNL3 gi28572990 CG3983 GNL3 66.0 4 5 ●
STRBP ƒ 8 19
RBM7 ƒ ● 1 2 ●
ZCC2 ƒ 4 5
Novelh
Spen gi24580579 CG18497 spen 600.0 7 15
RIMS1 gi62472639 CG33547 Rim 314.8 6 3
EXOSC10 gi161078302 CG7292 Rrp6 102.9 1 2
ZNF346, JAZ gi24583489 CG17098 73.2 3 7
SNED1 ƒ 6 2
a Proteins were identified by LC–MS-MS after separation by PAGE. Proteins identified in two out of two or two out of three preparations are shown (preparations
are numbered 1, 2, and 3). Proteins not reproducibly detected are summarized in Table S1 in the supplemental material. Proteins generally accepted to be common
contaminants, such as ribosomal proteins, are not shown. NH, no apparent/unambiguous homologue could be detected by BLAST searches at NCBI.
b The name of the human protein is given to aid comparison with previous studies of human spliceosomal complexes. Proteins are grouped in organizational and/or
functional subgroups.
c The presence of a protein is indicated by a number which represents the absolute number of peptides sequenced for that protein (see Materials and Methods for
details).
d Data from previous proteomics studies of MS2-affinity-selected human B and C complexes formed on an adenovirus-derived pre-mRNA substrate (MINX) (11)
or PM5 pre-mRNA (5), respectively, are also included. ●, presence of a given protein in these previously analyzed complexes.
e Œ, homologues could not be assigned on the basis of BLAST data.
f —, extensive homology between protein family members prevents assignment of Drosophila homologues on the basis of BLAST data.
g Human homologue previously detected in one or more human spliceosomal complex.
h Never detected in human spliceosomal complexes.
i ƒ, homology with several proteins, but only within conserved domains.
j LSm5 and LSm6 are difficult to detect by MS and have been included for completeness.
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cates that, in general, fewer hnRNP proteins associate with the
pre-mRNA in Drosophila nuclear extract, which could explain
why Drosophila H/A complexes exhibit a lower S value than
their human counterparts (Fig. 2). Interestingly, several pro-
teins, including IGF2BP1, RACK1, ZFR2, RBM15B, RBM42,
and the hnRNP proteins D, K, L, U, and UL2, were associated
with human B complexes formed on Ftz-M3 pre-mRNA but
were not detected previously in affinity-purified human B com-
plexes formed on the MINX-M3 substrate (11). As different
pre-mRNA substrates were used in these studies but the con-
ditions used to isolate B complexes were identical, these pro-
teins might represent substrate-specific components or, alter-
natively, contaminants.
A number of proteins that were detected in Drosophila Ftz B
complexes were absent from human Ftz B complexes. These
include, among others, the U1-associated protein FBP11 and
the splicing factor SF1. Interestingly, several Drosophila-spe-
cific proteins were identified whose human homologue either
was not previously found in spliceosomal complexes or simply
could not be identified by BLAST searches. Several of these
newly identified, spliceosome-associated proteins possess mo-
tifs found in many human spliceosomal proteins, such as an
RRM or zinc finger (see Discussion for details). Many of them
were also found in B complexes formed on a second pre-
mRNA substrate (Zeste62) and/or in Drosophila C complexes,
suggesting that they are bona fide spliceosomal proteins and
not contaminants. These data provide first insights into the
Drosophila spliceosome at the level of the B complex and
illustrate that its protein composition is very similar to that of
humans. However, despite this remarkable conservation in
composition, novel factors were also identified, some of which
have no apparent counterparts in humans.
Affinity selection of D. melanogaster B complexes assembled
on the short intron of the Zeste gene. To purify D. melanogaster
spliceosomal B complexes assembled on a short intron, we
constructed a pre-mRNA substrate containing the 62-nt Zeste
intron plus flanking exon sequences and three MS2 binding
sites at its 3 end (Fig. 1D). The Drosophila 62-nt Zeste intron
contains a polypyrimidine tract (in contrast to many other
short Drosophila introns), and it has been shown previously to
be spliced in vitro in Drosophila nuclear extract (52). When in
vitro splicing was performed with Kc nuclear extract, splicing
intermediates were first observed after 25 min (Fig. 1E, lane 5)
and products after 50 min (lane 9). Native gel analysis revealed
that B complexes first formed after 15 min of incubation (Fig.
1F, lane 3). A diffuse band migrating above the B complex
appeared after 30 min and most likely corresponds to the C
complex (Fig. 1F, from lane 6). Therefore, the 20-min time
point was chosen to purify Zeste62 B complexes.
B complexes formed on the Zeste62-M3 pre-mRNA sub-
strate were affinity-selected as described above for Ftz B com-
plexes, except that splicing was performed for 20 min. Dro-
sophila spliceosomes formed on Zeste62-M3 pre-mRNA
exhibited a sedimentation behavior identical to that of those
formed on Ftz-M3 pre-mRNA (Fig. 2A), i.e., H and A com-
plexes peaked in fractions 9 to 13 (20S to 25S) and B complex
in fractions 17 to 19 (45S). Affinity-purified complexes (Fig.
2B, left panels) contained nearly equimolar amounts of
uncleaved pre-mRNA, as well as U1, U2, U4, U5, and U6
snRNAs. Neither splicing intermediates nor products could
be identified in the eluate by autoradiography, confirming
that highly pure precatalytic B complexes had been isolated.
Protein composition of affinity-purified Drosophila B com-
plexes formed on Zeste62-M3. Proteins recovered from puri-
fied Zeste62-M3 B complexes were separated by 1D PAGE
and subsequently identified by LC–MS-MS. The protein com-
position of Drosophila B complexes assembled on Zeste62-M3
and Ftz-M3 pre-mRNA is highly similar (Table 1). In addition
to those proteins shared by Drosophila and human Ftz B com-
plexes, most proteins present in Drosophila Ftz-M3 B com-
plexes but absent from human Ftz-M3 B complexes were also
found in Zeste-M3 B complexes. Proteins identified in both
Drosophila B complexes are strong candidates for being bona
fide spliceosomal proteins commonly found in all Drosophila B
complexes, irrespective of the pre-mRNA substrate.
Zeste62-M3 B complexes contained several proteins not
detected in Drosophila Ftz-M3 B complexes. These include
proteins whose homologue was previously detected in human
spliceosomes, such as RBM10; HCNGP; AGGF1 (an A com-
plex-associated protein in humans; 3); SPF45, a U2-associated
protein with a dual function in alternative splicing and DNA
repair (10); PPIL4; Abstrakt; Q9BRR8; MORG1; and the
EJC-associated protein Acinus. Zeste62-M3 B complexes also
contained three additional SR proteins (9G8, Tra2, and Rbp1-
like/Srp20), as well as the hnRNP proteins hrp40.2 and
CG30122. Proteins not previously detected in human spliceo-
somal complexes that were solely found in Zeste B complexes
include the Drosophila homologues of SLC7A2, NCOA5, and
DNAJC17, as well as the Drosophila protein CG5343. Whether
these proteins contribute specifically to the assembly/function
of spliceosomes on short introns is currently not clear.
In contrast, only a few proteins were reproducibly detected
in Drosophila Ftz B complexes but were absent from Zeste62-M3
B complexes. These include Kin17 (hsKin17), which was previ-
ously detected in human spliceosomal complexes, and the newly
identified proteins PRPF38B and CG13597, a protein of un-
known function with no clear human homologue. Both of these
proteins are only represented by one or two peptides in Ftz-M3 B
complexes, so it is possible that they have been partially lost
during purification or that they might simply be contaminants. On
the other hand, these differences in composition may in some
cases be due to substrate-specific differences, including intron
length. Taken together, there appear to be only small differences
in the composition of B complexes assembled on the “short”
Zeste62 intron and the “long” Ftz intron.
EM of D. melanogaster spliceosomal B complexes formed on
Ftz-M3 pre-mRNA. To gain first insights into the structure of
Drosophila melanogaster spliceosomes, MS2 affinity-purified Ftz B
complexes were loaded onto a glycerol gradient containing glu-
taraldehyde in order to fix the particles (26). Particles from the B
complex peak gradient fractions were then negatively stained with
uranyl formate for EM analysis. In Fig. 3A, a typical EM overview
is shown on the left. The particles are evenly dispersed and appear
to be intact, as no smaller fragments are visible. Individual parti-
cles of the most-prominent view are shown on the right, together
with a schematic drawing of their general morphology. Drosoph-
ila B complexes exhibited a maximum dimension of 40 nm. In
the most-prominent view of the particles, two domains can be
distinguished: a triangular body, which consists of three branches
connected to a central mass, and a globular head region posi-
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tioned toward one side of the body. The lower branch of the
triangular body is referred to as the “foot,” the massive upper
branch as the “stump,” and the slim branch as the “neck”
(Fig. 3A, right). The head is attached on the “neck-stump”
side and consists of two regions: the elongated “head base”
located close to the body and a globular domain “head top”
located further away from the body. 2D class averages were
generated, and a gallery of several representative class av-
erages is shown in Fig. 3C (middle row). Importantly, the
general morphological features of the individual particles
FIG. 3. EM of affinity-purified Drosophila B complexes reveals structural similarities with human B complexes. (A and B) EM overviews and
single-particle images of negatively stained Drosophila B complexes formed on Ftz-M3 (A) or Zeste62-M3 (B) pre-mRNA in Kc nuclear extract.
A schematic of the predominant view of Drosophila Ftz or Zeste62 B complex with the various regions/domains indicated is shown at the right.
(C) Galleries of representative class averages of human B complexes formed on an adenovirus-derived pre-mRNA (top row), Drosophila B
complexes formed on Ftz-M3 (middle row), or Zeste62-M3 (bottom row) pre-mRNA. For each class, approximately 40 to 50 individual images
were averaged. The bar corresponds to 30 nm.
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are also observed in the 2D class averages. A visual com-
parison with 2D class averages of human B complexes
formed on an adenovirus-derived pre-mRNA substrate
(MINX-M3) (Fig. 3C, upper row) reveals that the Drosoph-
ila B complex closely resembles its human counterpart in
size, shape, and morphology, including apparent conforma-
tional heterogeneity in the head region as previously re-
ported for the human B complex (11). Thus, not only the
protein composition but also the structure of the Drosophila
spliceosomal B complex is strikingly similar to its human
counterpart. These data show a remarkable conservation of
spliceosome composition and appearance across two evolu-
tionarily distant organisms.
EM analyses of D. melanogaster spliceosomal B complexes
formed on Zeste62-M3 pre-mRNA. To investigate whether
there are differences in the appearance of Drosophila spliceo-
somal B complexes assembled on long versus short introns, B
complexes formed on the Zeste62-M3 pre-mRNA were also
subjected to EM analyses. The EM overview (Fig. 3B, left
panel) shows evenly dispersed particles of comparable size. A
gallery of individual images of the most-predominant view of
the particle, with a schematic drawing, is shown on the right. In
contrast to Drosophila B complexes formed on the Ftz-M3
pre-mRNA, which appear rhombic in shape, Zeste62-M3 B
complexes exhibit a more-compact, triangular appearance and
also have slightly smaller dimensions (35-nm maximum); this
is particularly apparent in the 2D class averages (Fig. 3C, lower
panel). Nevertheless, the massive axis formed by the foot,
central mass, and stump is clearly distinguishable. In addition,
the head region of Drosophila Zeste62-M3 B complexes is
smaller than this region of their human or Drosophila Ftz-M3
counterparts. Furthermore, an additional, crooked domain is
visible at the distal tip of the foot in several class averages.
Compared to Ftz-M3 B complexes, Zeste62-M3 B complexes
exhibit more well-defined internal structures, indicating that
they are structurally more homogeneous. In summary, the
2D projections of Drosophila B complexes assembled on
Zeste62-M3 pre-mRNA have significant similarities with those
of Ftz-M3 Drosophila B complexes. The observed structural
dissimilarities could result from slight differences in the protein
composition of these complexes, the smaller intron size, and/or
differences in the orientation of particles on the carbon film.
Isolation of D. melanogaster spliceosomal C complexes as-
sembled on an MS2-tagged Ftz pre-mRNA substrate lacking a
3 exon. To determine whether there is an exchange of D.
melanogaster spliceosomal proteins during the B-to-C transi-
tion, we next set out to isolate Drosophila C complexes. Re-
cently, highly pure and catalytically active human C complexes
assembled on an MS2-tagged pre-mRNA substrate lacking a 3
ss and 3 exon were purified from HeLa nuclear extract and
analyzed by MS (5). To isolate Drosophila C complexes, we
modified the Ftz pre-mRNA substrate such that it contained a
5 exon with three MS2 binding sites, an intron with a branch
site, and a 29-nt pyrimidine tract but lacked a 3 ss and 3 exon
(Fig. 4A). To test whether this substrate, designated M3-Ftz-
longPYT, was able to undergo the first step of splicing, in vitro
splicing was performed with Kc nuclear extract. Splicing inter-
mediates (i.e., excised 5 exon and lariat intron) were first
observed after 30 min (Fig. 4b, lane 4) and accumulated at
later time points. As expected, no splicing products were ob-
served. Analysis of splicing complexes on a native polyacryl-
amide gel revealed that first A and B, and later, C complexes
were formed (Fig. 4C). After 180 min of incubation, a signif-
icant portion of unspliced pre-mRNA was still present and
most likely represents earlier stages of spliceosomal assembly,
i.e., H, E, A, B, and B* complexes. In order to reduce the
amount of these contaminating complexes, RNase H digestion
with DNA oligonucleotides complementary to nt 6 to 17
and nt 18 to 30 of the 5 exon (relative to the 5 ss) was
performed. The levels of pre-mRNA, but not cleaved 5 exon,
were reduced (Fig. 4B, compare lanes 7 and 9). Visualization
of splicing complexes on a native gel prior to and after cleavage
by RNase H confirmed that the levels of H, A, and B complex,
but not C complex, were reduced (Fig. 4C, cf. lanes 2 and 7 and
lanes 6 and 8).
C complexes formed on the M3-Ftz-longPYT pre-mRNA
were affinity purified under conditions identical to those de-
scribed above for the purification of B complexes (i.e., at 150
mM salt and in the absence of heparin), except that splicing
was performed for 180 min and was followed by RNase H
digestion. Spliceosomal C complexes peaked in fractions 19 to
22 after glycerol gradient centrifugation, indicating that Dro-
sophila C complexes exhibit a slightly higher sedimentation
coefficient (50S) than B complexes (40S to 45S) (Fig. 4E).
Affinity-purified complexes contained splicing intermediates,
U2, U5, and U6 but no U1 and U4 (Fig. 4D, upper panel),
consistent with their designation as C complexes. However, in
addition to splicing intermediates, purified complexes also con-
tained unspliced pre-mRNA (Fig. 4D, lower panel). As both
U1 and U4 were essentially absent, the latter complexes most
likely represent activated B* spliceosomal complexes. Quanti-
fication of the radioactive bands corresponding to first-step
intermediates and residual unspliced pre-mRNA revealed that
the eluate contained 75% C complex, with the remaining
25% presumably B* complexes.
Comparison of the protein compositions of Drosophila spli-
ceosomal B and C complexes. Proteins present in affinity-
purified Drosophila C complexes were separated by protein gel
electrophoresis and subsequently identified by LC–MS-MS.
Approximately 100 proteins were reproducibly identified, ho-
mologues of which were in most cases also previously found in
human C complexes (Table 1) (5). Sixty of the C complex-
associated proteins were also consistently observed in purified
Drosophila Ftz B complexes. These include nearly all U2 and
U5 snRNP proteins, Prp19/CDC5 complex and Prp19-related
proteins, and most SR proteins, plus numerous other non-
snRNP proteins. If the protein composition of purified Dro-
sophila Ftz B and C complexes is compared, several differences
are apparent. As expected, U1 and U4/U6 snRNP proteins are
lost during C complex formation, consistent with U1 and U4
snRNA dissociation. Note that the Drosophila protein sans-fille
(snf) is the functional homologue of both U1-A and U2-B	 and
is therefore still represented in the table as a U1 snRNP pro-
tein. The apparent absence of LSm proteins is consistent with
the results of previous studies in humans and yeast demon-
strating the loss of these proteins during catalytic activation (5, 9).
Additional proteins lost include 17S U2-related proteins (e.g.,
SPF30 and U2AF35/65), tri-snRNP-specific proteins (110K, 65K,
and 27K), and a number of non-snRNP proteins. Interestingly,
there appears to be some general reduction in the peptide num-
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bers observed for SF3a/b proteins, suggesting that, similar to the
situation in humans (5), these proteins are also destabilized in
Drosophila during the B-to-C transition (and thus less abundant
in C complexes). However, additional studies, i.e., immunoblot-
ting, will be required to clarify whether these proteins are truly
underrepresented.
A number of proteins, on the other hand, were solely/pre-
dominantly identified in C complexes, indicating that they are
recruited during catalytic activation or the first step of splicing.
These include the known second-step factor Prp22 and DEAD
box helicases and peptidyl-prolyl isomerases (PPIases) that
were also identified in purified human C complexes (e.g.,
Abstrakt, DDX35, PPIL2, and PPIG) (5). Most factors com-
prising the core of the EJC in vertebrates (i.e., eIF4A3, Magoh,
and Y14), as well as additional EJC-associated proteins, were
either first detected in C complexes or appear to be more
abundant in C than in B, as evidenced by an increase in the
number of peptides identified. In addition, several proteins
that were previously identified in purified human C complexes
join Drosophila spliceosomes during the transition from B
to C complex, namely cactin, SKIV2L2, NOSIP, CXorf56,
DGCR14, NKAP, and CDK10. Further, there are additional
putative novel spliceosomal proteins which appear to associate
with the Drosophila spliceosome during the B-to-C transition.
These include, among others, three Drosophila proteins
(CG11808, CG6209, and CG5877) without apparent homo-
logues in humans. Previous studies reported that components
of the Prp19/CDC5 complex and related proteins are more
abundant in the human C complex than in the B complex,
based on an increase in the number of peptides sequenced for
these proteins and immunoblotting data (5). The apparent
stabilization of these proteins during the B-to-C transition
appears to occur in Drosophila as well, as there are consistently
more peptides of these proteins detected in the Drosophila C
complex than in the B complex. In summary, the compositional
dynamics of the spliceosome during the transition from the
precatalytic B complex to the catalytically active C complex are
largely conserved between humans and flies.
MS2 affinity purification of spliced and unspliced Drosoph-
ila mRNPs. To determine whether EJC proteins are deposited
on Drosophila melanogaster mRNAs in a splicing-dependent
manner, we also affinity purified spliced and unspliced Ftz
mRNPs. To isolate unspliced Ftz mRNPs, we constructed a
substrate lacking the intronic region of Ftz-M3 pre-mRNA
(i.e., corresponding to spliced Ftz-M3 mRNA; FtzI-M3) (Fig.
5A). 32P-labeled Ftz-M3 pre-mRNA or Ftz-M3 mRNA (from
the construct lacking an intron) was incubated for 180 min
under splicing conditions in Drosophila Kc cell nuclear extract.
FIG. 4. Affinity purification of Drosophila C complexes. (A) Schematic representation of the M3-Ftz-longPYT pre-mRNA substrate. PY tract,
polypyrimidine tract; nts, nucleotides. (B) Splicing was performed with M3-Ftz-longPYT pre-mRNA in Kc cell nuclear extract for the times
indicated (in minutes) above each lane. In lanes 8 and 9, DNA oligonucleotides complementary to the Ftz 5 exon (nt 6 to 17 and nt 18 to
30 relative to the 5 ss) were added after 10 min or 180 min of splicing, and the reaction mixture was incubated for an additional 20 min to allow
RNase H digestion of early spliceosomal complexes. RNA was recovered, analyzed on a 12% polyacrylamide–8 M urea gel, and visualized by
autoradiography. Splicing substrates, intermediates, and products are indicated on the right. *, RNase H digestion product. (C) Splicing complexes
were analyzed on a 3.5% native polyacrylamide gel and visualized by autoradiography. The positions of the H, A, B, and C complexes and RNase
H digestion products (*) are indicated on the right. (D) RNA composition of MS2-affinity-purified C complexes. Gradient containing Ftz C
complexes formed in Kc extract (fractions 19 to 22) was pooled and subjected to MS2 affinity selection. Bound complexes were eluted with maltose,
and RNA was recovered, separated by denaturing PAGE, and visualized by silver staining (upper panel) or by autoradiography (lower panel). The
positions of the snRNAs, unspliced pre-mRNA, and splicing products/intermediates are indicated on the right. (E) Splicing reaction mixtures
containing Ftz-M3 pre-mRNA or M3-Ftz-longPYT pre-mRNA were subjected to glycerol gradient centrifugation. The radioactivity contained in
each gradient fraction was determined by Cherenkov counting and expressed as the percentage of the total 32P-RNA loaded onto the gradient.
Sedimentation coefficients, indicated by arrowheads, were determined by analyzing the UV absorbance of fractions of a reference gradient
containing prokaryotic ribosomal subunits.
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After 180 min, a large portion of the pre-mRNA had been
converted to mRNA (Fig. 5B, cf. lanes 4 and 5). To reduce the
amount of unspliced pre-mRNA or intron-containing interme-
diates, RNase H digestion was carried out with two oligonu-
cleotides complementary to Ftz intron sequences. As shown in
Fig. 5B, the addition of the oligonucleotides led to a reduction
in pre-mRNA and intron lariat levels (cf. lanes 5 and 6). The
levels of spliced and unspliced Ftz-M3 mRNA, on the other
hand, remained unaffected.
Drosophila mRNPs were affinity purified under conditions
identical to those described above for the purification of B and
C complexes. mRNPs formed on spliced and unspliced Ftz-M3
mRNA exhibit a similar sedimentation behavior, with a main
peak in both cases in fractions 10 to 12 (20S to 25S) (Fig.
5C). In reactions performed with Ftz-M3 pre-mRNA, a second
peak was observed in fractions 15 to 17 (35S) and appeared
to contain spliceosomal complexes resistant to RNase H-me-
diated cleavage (data not shown). The mRNP peak gradient
fractions (i.e., fractions 10 to 12) were pooled and subjected to
MS2 affinity selection. The eluates contained essentially only
mRNA and, in reactions performed with Ftz-M3 pre-mRNA,
small amounts of pre-mRNA (
8%) (Fig. 5D), confirming
that relatively pure mRNPs had been affinity purified.
Protein composition of purified Drosophila melanogaster
mRNPs. Proteins were recovered from the eluates, separated
by 1D PAGE, and subsequently identified by LC–MS-MS (Ta-
ble 2). More than 75 proteins were reproducibly detected in
spliced Ftz mRNPs. However, a subset of these, in particular
copurifying snRNP proteins or components of the 3-end pro-
cessing machinery (e.g., CPSF1 to -6), likely do not represent
bona fide mRNP proteins, but rather contaminants (see Dis-
cussion). The majority of proteins identified in spliced mRNPs
were also found in unspliced mRNPs, indicating that they can
be deposited onto the mRNA in a splicing-independent man-
ner. Proteins shared by both include the cap binding proteins
CBP20 and CBP80, SR proteins, several snRNP proteins, and
a large number of proteins previously detected in human spli-
ceosomes and/or in Drosophila spliceosomes (see Table 1). A
total of 19 proteins were exclusively detected in spliced
mRNPs, indicating that they are deposited on the mRNA as a
consequence of splicing. These included core components of
the mammalian EJC, such as MLN51 (Barentsz in Drosophila),
Magoh, and Y14. eIF4AIII was also detected in two out of
three preparations of unspliced mRNP, but based on peptide
numbers, it appears to be more abundant in spliced mRNPs.
Only two components of the THO/TREX complex (THOC2
and THOC5), which play a role in mRNA export, were identified
in spliced mRNPs. Interestingly, homologues of the human EJC-
associated factor Upf2, and also Upf1, which are both involved in
NMD, were identified solely in spliced mRNPs. Homologues of
three proteins previously identified in human spliceosomes
(SKIV2L2, EIF2C2, and RANBP2) were also specifically associ-
ated with spliced Drosophila mRNPs, together with a few proteins
not previously detected in human spliceosomal complexes (e.g.,
FIG. 5. MS2 affinity selection of in vitro spliced and unspliced mRNPs. (A) Schematic representation of the Ftz-M3 pre-mRNA and FtzI-M3
mRNA. PY tract, polypyrimidine tract; nts, nucleotides. (B) FtzI-M3 or Ftz-M3 RNA was incubated for 180 min under splicing conditions in Kc
cell nuclear extract, followed by oligonucleotide-directed cleavage by RNase H. Splicing substrates, intermediates, and products are indicated on
the right. (C) Splicing reaction mixtures containing Ftz-M3 or FtzI-M3 were loaded onto a linear 10-to-30% (vol/vol) glycerol gradient containing
G150 buffer. The radioactivity contained in each fraction was determined by Cherenkov counting. The profiles show the percentage of radioactivity
in each fraction. Sedimentation coefficients (indicated by arrowheads) were determined by analyzing the UV absorbance of fractions of a reference
gradient containing prokaryotic ribosomal subunits. (D) Gradient fractions 10 to 12 were pooled and subjected to MS2 affinity selection. Bound
complexes were eluted with maltose, and RNA was recovered, separated by 12% denaturing PAGE, and visualized by silver staining (upper panel)
or by autoradiography to detect radioactive species (lower panel). Lanes 1 and 4, 2.5% of the input (I) pooled gradient fractions. Lanes 2 and 5,
2.5% of the flowthrough (FT) of the amylose column. Lanes 3 and 6, 10% of the eluted (E) mRNPs. The positions of snRNAs, unspliced
pre-mRNA, and splicing products are indicated on the right.
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TABLE 2. Protein composition of affinity-selected Drosophila mRNPsa
Human proteinb
Drosophila melanogaster protein Presence of or absolute no. of peptides sequenced forproteinc in indicated mRNP
GenBank







M3d1 2 3 1 2 3
EJC and TREX
eIF4AIII gi24645031 CG7483 eIF4AIII 45.6 18 21 18 6 8 ●
MLN51 gi45551990 CG12878 btz 86.1 11 6 7
Magoh gi17136332 CG9401 mago 17.3 4 3 4 ●
Y14 gi24651979 CG8781 tsu 19.0 4 3 2 ●
Acinus gi24585110 CG10473 hkl 83.7 8 3 5 15 2 11 ●
SAP18 gi17738001 CG6046 bin1 17.3 3 2 1 4 2 4 ●
THOC2 gi24581012 CG31671 Tho2 188.5 1 1 1 ●
THOC5 gi19922862 CG2980 thoc5 70.9 2 2 1 ●
Upf1 gi18859757 CG1559 Upf1 129.9 2 2 7
Upf2 gi24640488 CG2253 Upf2 140.1 7 4 8
Cap binding complex
CBP20 gi17738031 CG12357 Cbp20 17.7 4 2 1 2 ● ●
CBP80 gi24639721 CG7035 Cbp80 93.2 11 16 11 22 15 11 ● ●
hnRNP: —e gi22024201 CG30122 81.0 3 1 1 6 3 5
SR proteins, SR related
SF2/ASF gi21358097 CG6987 SF2 28.4 25 13 12 26 18 14 ●
9G8 gi24582360 CG10203 xl6 27.9 13 6 7 13 12 9 ●
SRp20 gi24641772 CG1987 Rbp1-like 16.8 7 5 4 10 7 ● ●
SRp55 gi28571701 CG10851 B52 42.8 14 11 8 22 14 20 ●
SC35 (SFRS2) gi45552333 CG5442 SC35 21.4 9 7 6 10 11 10
RSRC2 gi24642204 CG6340 56.7 4 1 3 3
SRm300 gi161080550 CG7971 127.3 9 2 3
SRm160 gi24663664 CG11274 SRm160 107.6 1 1 2
NH gi28571148 CG7065 136.8 3 2 3 2
Copurifiying snRNP proteins
B gi17136806 CG5352 SmB 21.0 3 1 3 1 2
D2 gi21357623 CG1249 SmD2 13.5 1 3 ●
U1-70K gi17137278 CG8749 U1-70K 52.9 3 1 3 ●
U1-A/U2-B	 gi17737284 CG4528 snf 24.6 2 1 1 1 1
SF3b130 gi24654874 CG13900 136.6 1 3 2 ●
PUF60 gi24655242 CG12085 pUf68 67.9 4 2 10 3 9
U5-220K gi20129897 CG8877 prp8 279.4 6 4 2 17 1 6 ● ●
U5-200K gi28574898 CG5931 244.5 10 1 5 ● ●
U5-116K gi21357743 CG4849 110.7 1 3 6 1 2 ●
U5-102K gi24666532 CG6841 105.2 5 1 5 1 3 ●
U5-100K gi24584994 CG10333 94.6 2 2 2 3 2 5 ●
U4/U6-60K gi21355245 CG6322 61.6 1 1 ●
Copurifiying spliceosomal proteins
MGC2803 gi24643383 CG18809 11.4 1 1 1 1
RBM10 gi24580815 CG4887 114.2 2 3 5 2 5
RBM39/RNPC2 gi45550943 CG11266 66.5 1 2 4
TLS/FUS gi24642436 CG3606 caz 38.8 7 3 3 9 2 5
ZC3H18/LOC124245 gi24640344 CG1677 109.1 7 1 3 6 2 ●
YBX-1 gi24663131 CG5654 yps 38.9 14 5 11 16 7 2 ● ●
ASR2B gi24585960 CG7843 107.2 14 10 9 16 8 19 ● ●
p68/DDX5 or DDX17 gi45551833 CG10279 Rm62 78.5 3 6 15 12 16 ●
Abstrakt gi17977678 CG14637 abs 69.5 1 4 6
KIAA1604 (fSAPb) gi24584968 CG12750 ncm 151.6 3 2
hPRP22 gi20129977 CG8241 pea 142.0 2 1 2 2
Hsp73 (CCAP1) gi28571721 CG4264 Hsc70-4 71.1 11 5 5 3
hPRP4-kinase/PRPF4B gi19922978 CG7028 104.0 3 3 4
PPIG, SR-Cyp gi28571910 CG1866 Moca-cyp 116.4 1 1 1 1 2
PABP gi45552715 CG5119 PABP 69.9 18 8 18 13 7 10
RBM4 gi24659981 CG8597 lark 39.9 14 6 8 9 8 10
ZFR2 gi28574893 CG5215 Zn72D 96.0 1 1 1 3 1 2
WDR33 gi24644363 CG1109 90.5 5 4 7 8 4 6
Continued on following page
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Drosophila melanogaster protein Presence of or absolute no. of peptides sequenced forproteinc in indicated mRNP
GenBank







M3d1 2 3 1 2 3
RBM15B gi24586450 CG2910 nito 89.1 8 3 3 12 4 8
Copurifiying spliceosomal proteins
CPSF1 gi45552619 CG10110 CPSF 164.7 19 15 17 32 11 19
CPSF2 gi24650920 CG1957 85.4 9 3 4 8 5 6
CPSF3 gi24648013 CG7698 76.8 5 4 10 8 7 8
CPSF5 gi116007798 CG3689 23.0 27 14 14 21 13 19
CPSF6 gi21355973 CG7185 71.1 30 16 22 40 29 27
GEMIN5 gi45550470 CG30149 rig 137.8 7 5 11 3 5
FIP1L1 gi24644016 CG1078 78.6 4 3 4 1 4
NY-CO-10 gi21357249 CG10907 56.6 2 1
CPSF4 gi17137188 CG3642 clp 33.5 2 2 2 3
CDK10, PISSLRE gi24652305 CG1362 cdc2rk 39.4 2 3 2
SKIV2L2 gi17864608 CG4152 lethal(2)35Df 118.9 1 1
EIF2C2 gi24664668 CG7439 Ago2 136.9 4 3
RANBP2 gi45550830 CG11856 Nup358 296.4 4 3
MTHFSD gi161078016 CG14648 growl 58.8 10 31 10 13 14 13
SPN gi45550712 CG9684 71.9 53 48 40 37 26
IGF2BP1 gi116007146 CG1691 imp 63.4 16 7 16 4 3 2
PIWIL1 gi161076864 CG6137 aub 98.6 6 6 10 8 6
PRPF38B gi24641727 CG1622 45.4 2 2 3 3
NCOA5 gi17647723 CG8614 Neos 42.6 4 2 4 3
C2orf30 gi24583799 CG6766 59.8 5 11 15 12 19
APTX gi24648185 CG5316 76.5 8 6 9 5 2 3
LUC7-like gi24665973 CG7564 48.4 2 6 6
PSME3 gi18860055 CG1591 REG 28.1 1 1 1
NH gi24653446 CG6209 mst101(2) 69.0 10 10 9 12 10 10
NH gi24656457 CG8994 exu 58.0 7 6 13 6 12 8
Miscellaneous in both
NXF2 gi45551570 CG4118 nxf2 96.6 4 1 1 1
Symplekin gi24644386 CG2097 132.1 10 11 14 17 9 20
NH gi24641127 CG2186 122.7 16 5 10 4 2
RBM26 gi24585249 CG10084 swm 115.7 2 4 2 3
PYGM gi78706832 CG7254 GlyP 97.0 1 3 1 1
NH gi62484342 CG9776 140.3 5 5 5 12 4 6
NH gi24664166 CG3836 stwl 112.9 9 8 7 6 6 13
NH gi45550425 CG6701 143.3 2 3 6 8 9 7
Miscellaneous in unspliced only
RAPTOR gi24640048 CG4320 raptor 177.5 5 5 3
NH gi24653724 CG10205 13.6 2 2 2
NH gi24649669 CG17780 39.5 5 5 3
NH gi28573576 CG8929 68.0 1 1
Miscellaneous in spliced only
DNAJA4 gi24646562 CG8863 45.2 5 1 5 1
NH gi24644051 CG12001 59.8 11 13 13 12
SLC26A11 gi19922482 CG5002 65.1 2 4
DDX43 gi21355075 CG7878 78.6 1 2
NH gi24668137 CG7597 128.4 2 2 5
ADAM10 gi24651113 CG1964 kul 168.8 2 2
KIAA0265 gi24655044 CG5186 slim 69.7 1 2
NH gi24583347 CG5381 76.9 3 2 5
a Proteins were identified by LC–MS-MS after separation by PAGE. Proteins identified in at least two out of three preparations are shown (preparations are
numbered 1, 2, and 3). Proteins not reproducibly detected are summarized in Table S2 in the supplemental material. Proteins generally accepted to be common
contaminants, such as ribosomal proteins, are not shown. NH, no apparent/unambiguous homologue could be detected by BLAST searches at NCBI.
b The name of the human protein is given to aid comparison with previous studies of human mRNP complexes. Proteins are grouped in organizational and/or
functional subgroups.
c The presence of a protein is indicated by a number which represents the absolute number of peptides sequenced for that protein (see Materials and Methods for
details).
d Data from a previous proteomics study of MS2 affinity-selected spliced (AdML-M3) or unspliced (AdMLI-M3) human mRNPs formed on adenovirus (Ad)-
derived pre-mRNA substrate (33) are also included; a dot represents the presence of a given protein in these previously analyzed complexes.
e —, extensive homology between protein family members prevents assignment of Drosophila homologues on the basis of BLAST data.
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DNAJA4, SLC26A11, DDX43, ADAM10, KIAA0265, and
CG5381, which has no apparent human homologue). Taken to-
gether, these data indicate that, as in humans, many components
of the EJC are deposited onto the mRNA in a splicing-dependent
manner.
DISCUSSION
Here we have shown that the composition of spliceosomal B
and C complexes is largely conserved between humans and
flies. We also identified several Drosophila-specific spliceo-
some-associated proteins which may be novel splicing factors.
Our studies revealed that the compositional dynamics during
the transition from the precatalytic B to catalytically active C
are also very similar in both organisms. By performing EM, we
further demonstrated that human and Drosophila B complexes
share a nearly identical 2D structure. A comparison of Dro-
sophila spliceosomes formed on short versus long introns indi-
cated that although there are only small differences in their
protein compositions, their 2D structures clearly differ. Finally,
by comparing the composition of unspliced and spliced Dro-
sophila mRNPs, we provide evidence that many components of
the EJC are deposited onto Drosophila mRNAs as a conse-
quence of splicing. Our studies reveal a remarkable conserva-
tion of the composition and structure of human and Drosophila
spliceosomes, as well as their compositional dynamics during
catalytic activation.
Most spliceosomal proteins are evolutionarily conserved be-
tween humans and flies. Homologues of the vast majority of
human spliceosomal proteins were detected in affinity-purified
Drosophila B and C complexes. Due to the large number of
proteins identified in human spliceosomes (over 150), there
has been much discussion as to whether all of the identified
factors are bona fide spliceosomal proteins. Most of those
proteins identified in both human and Drosophila spliceosomes
very likely comprise the set of functionally important factors
common to most metazoan spliceosomes. It is unlikely that all
proteins detected in both organisms are directly involved in
splicing. Rather, some of them may have important roles in
coupling the splicing machinery to other macromolecular com-
plexes in the nucleus, including those involved in transcription
and polyadenylation. Proteins found in only human or Dro-
sophila spliceosomes are more likely to be contaminants, al-
though some of them may have species-specific roles in splicing
(see below). The conserved composition of Drosophila and
human spliceosomes is also reflected in their 2D structure as
evidenced by EM. That is, a highly similar morphology was
observed for both B complexes (Fig. 3). This suggests that
higher-order interactions and the general spatial organization
of spliceosomal subunits are also conserved between these
evolutionarily distant organisms.
Identification of putative, novel spliceosomal proteins in
Drosophila. A number of novel proteins, whose homologues
have not been detected to date in human spliceosomal com-
plexes, were identified in Drosophila spliceosomal complexes
(summarized in Table S3 in the supplemental material), sug-
gesting that they might be specifically involved in Drosophila
splicing or in coupling the Drosophila spliceosome to other
molecular machines in the nucleus. Several proteins were
found in Drosophila complexes assembled on both the Zeste62
and Ftz pre-mRNA and thus could represent Drosophila-spe-
cific splicing factors required for the splicing of most introns. It
should be noted, however, that some of the compositional
differences observed been Drosophila and human spliceo-
somes might not be species-specific differences but rather arise
due to differences in the cell lines used, the proteins expressed
in them, and/or the extracts derived from them.
Some of the newly detected proteins have no known func-
tion but contain motifs or domains often found in splicing
factors, adding credence to the idea that they are bona fide
spliceosomal proteins. For example, CG7564 is closely related
to the yeast U1-associated protein LUC7, which is involved in
5 ss recognition in yeast (15). QKR58E-1, whose function is
unknown, contains a KH domain, which is found in many
proteins involved in RNA metabolism. CG1622 contains a
Prp38 domain and is closely related to the tri-snRNP-associ-
ated Saccharomyces cerevisiae protein Prp38. No functions are
known for the proteins rin and neos, but both contain an RRM
motif, which is also characteristic of proteins involved in RNA
metabolism. Aub and pep are also of particular interest as both
proteins are thought to be involved in mRNA metabolism
(http://beta.uniprot.org/). Aub has been shown to be required
for proper localization of oskar mRNA in developing oocytes
(reviewed in reference 21), and pep contains a C2H2-type zinc
finger and is associated with hnRNP complexes (1). Many of
the other proteins identified have been implicated in other
cellular processes, such as DNA repair, cell cycle regulation, or
protein transport (http://beta.uniprot.org/) (see Table S3 in the
supplemental material). While this suggests that they might be
contaminants, it is also possible that they have dual functions
(i.e., an additional role in splicing) and/or are involved in
coupling the spliceosome to other nuclear processes. Further
studies are required to determine which of the newly identified
proteins represent true components of Drosophila spliceo-
somes.
The compositional dynamics of the spliceosome are evolu-
tionarily conserved. Comparative proteomics of human spli-
ceosomes isolated at different stages has revealed that the
spliceosome’s composition is highly dynamic (reviewed in ref-
erences 23 and 59). The most-dramatic change appears to
occur during catalytic activation, which is accompanied by
large RNP remodeling events (5). A comparison of the com-
position of precatalytic B and catalytic C complexes from Dro-
sophila revealed that the recruitment and release of factors
during catalytic activation is highly conserved between humans
and flies. As in humans, 40 B complex proteins are lost
during the B-to-C transition in Drosophila, suggesting that
these factors are required prior to the first step of splicing. On
the other hand,35 factors are recruited at this stage. As is the
case in humans, factors required for the catalytic steps of
splicing (e.g., Prp22), as well as components of the EJC com-
plex, are first detected in the C complex (see below). However,
in contrast to the situation in humans, the second-step factors
Prp16 and Prp18 were not detected in affinity-purified Dro-
sophila C complexes and Slu7 was detected in only one Dro-
sophila C complex preparation. Thus, these factors may be less
stably associated and for the most part lost during the purifi-
cation of Drosophila C complexes or, alternatively, they may be
generally difficult to detect by MS. As in humans, the second-
step factor hPrp17 and the first-step factor hPrp2, on the other
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hand, were found already in Drosophila B complexes, suggest-
ing that these factors are recruited prior to step I of splicing.
Taken together, our results indicate that several functionally
important protein recruitment events taking place after B com-
plex formation are conserved among humans and flies.
The results of recent studies indicate that two major desta-
bilization and stabilization events accompany the B-to-C tran-
sition in humans. Specifically, marked changes in the absolute
number of peptides sequenced during MS coupled with the
results of immunoblotting experiments indicated that there is a
reduction in proteins comprising the U2-associated hetero-
meric complexes SF3a and SF3b (5). In contrast, proteins of
the Prp19/CDC5 complex (and related proteins) appear to be
more abundant (5). This suggests that the former proteins are
destabilized, whereas the latter are stabilized, during catalytic
activation—an indication that RNA-protein and protein-pro-
tein interactions are remodelled during this stage. A compar-
ison of the peptides sequenced for SF3a/b and Prp19/CDC5-
associated proteins in Drosophila B versus C complexes
suggests that similar destabilization/stabilization events (i.e.,
RNP remodeling) are also occurring in Drosophila. The appar-
ent conservation of these remodeling events underscores their
importance during the catalytic steps of pre-mRNA splicing.
Compositional and structural differences between B com-
plexes formed on a long versus short Drosophila intron. In
contrast to mammals, a large percentage of introns in Drosoph-
ila pre-mRNAs are less than 80 nt in length. These short
introns cannot be spliced in mammals and may accordingly
exhibit compositional differences from “long” Drosophila in-
trons, which can be spliced in HeLa nuclear extract. It is
thought that there are mechanistic differences between the
initial recognition of splice sites defining small versus long
Drosophila introns (52). Here we compared the composition of
spliceosomal complexes formed on the 62-nt Zeste intron with
that of complexes formed on the 147-nt-long Ftz intron. Inter-
estingly, the results of previous studies indicate that the se-
quence requirements for A complex formation differ between
Ftz and Zeste62 in that the latter requires both the 3 and 5 ss
for complex formation (52), whereas, similar to vertebrate
introns, an A-like complex forms on the isolated Ftz 3 exon
plus flanking sequences, including the BPS and polypyrimidine
tract (50). As both introns have similar 3 ss sequences and
uninterrupted polypyrimidine tracts of similar length, i.e., 12
(Zeste) versus 11 (Ftz), the mechanistic basis for this difference is
not clear, but this region of Zeste62 apparently does not support
stable U2 snRNP association on its own. Initial attempts to isolate
pure Zeste62 and Ftz A complexes were not successful, and thus,
we instead affinity selected B complexes.
Only a few proteins were differentially associated with
Zeste62 versus Ftz B complexes. One particularly interesting
difference is the presence of three additional SR proteins
(9G8, SRp20, and SFRS10) in Zeste62 B complexes. SR pro-
teins play important roles during early splicing complex for-
mation and are involved in splice site recognition, bridging the
5 and 3 ends of the intron and stabilizing the interaction of
snRNPs with the pre-mRNA (reviewed in reference 47). Thus,
the expanded subset of SR proteins found in Zeste62 B com-
plexes could potentially reflect unique cross-intron interactions
in short introns that are required for stable A complex forma-
tion. Zeste62 complexes also specifically contained four novel
proteins (CG7255, neos, CG17187, and CG5343). CG17187 is
a member of the DNAJ family of proteins, several members of
which are found in human snRNPs or spliceosomes (e.g.,
DNAJC6 or SPF31), and neos contains an RNA binding motif
(RRM). To date, no functions have been described for either
of these proteins. CG7255 contains an amino acid permease
domain (http://www.expasy.org/prosite/) and is probably in-
volved in the transport of amino acids, whereas CG5343 con-
tains a domain of unknown function (DUF667) and has been
suggested to be a transcription factor. As the sequences of
Zeste62 and Ftz differ, the recruitment of unique proteins may
be related purely to sequence differences rather than to intron
length. Thus, it is presently not clear if one or more of these
proteins are specifically involved in forming spliceosomal com-
plexes on short introns. Clarification of this issue will require a
detailed dissection of the function of those proteins specifically
associated with Zeste62 spliceosomal complexes.
Despite their nearly identical protein composition, EM stud-
ies indicated that there are structural differences between
Zeste62 and Ftz B complexes. The former appear more com-
pact and have a smaller head region. Interestingly, the head
domain of the human B complex has been proposed to contain
the main components of the A complex (46). Consistent with
apparent mechanistic differences between long and short in-
trons at the early stages of splicing complex formation, a
smaller head domain suggests differences in the spatial orga-
nization and/or composition of components comprising this
domain. In the future, a more-detailed analysis, including EM
immunolabeling of spliceosomal components and 3D recon-
structions, may reveal in more detail structural differences be-
tween spliceosomes formed on short and long Drosophila
introns.
EJC complex proteins are recruited in a splicing-dependent
manner after B complex formation. In addition to B and C
complexes, we also affinity selected Drosophila mRNPs formed
on Ftz mRNA. MS analyses detected 75 proteins copurifying
with affinity-purified spliced or unspliced mRNPs. Given that
both mRNPs have an S value of 22S, a subset of the identi-
fied proteins likely represent contaminants and/or are present
in substoichiometric amounts. These include, among others,
CPSFs (cleavage/polyadenylation specificity factors) and many
snRNP proteins, which are not considered to be mRNP asso-
ciated. Despite the large number of proteins identified, a com-
parison of spliced and unspliced mRNPs can still provide in-
formation about proteins that are recruited to mRNPs as a
consequence of splicing.
Spliced Drosophila mRNPs contained several proteins not
present in their unspliced counterparts, including components
of the EJC. Specifically, we detected Drosophila homologues of
the core components of the mammalian EJC (i.e., eIF4AIII,
MLN51, Magoh, and Y14). With the exception of eIF4AIII,
these proteins were exclusively found in preparations of spliced
Ftz-M3 mRNP. The presence of eIF4AIII in unspliced mRNP
is consistent with the results of recent pull-down experiments
performed with extracts from Drosophila S2 cells expressing a
glutathione S-transferase-tagged version of eIF4AIII; these
studies revealed the association of eIF4AIII with both spliced
and unspliced pre-mRNA/RNAs, indicating that the binding of
eIF4AIII is not splicing dependent in Drosophila (60). Human
eIF4AIII, Magoh, and Y14 form a trimeric complex in the
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absence of MLN51 (Barentsz in Drosophila), suggesting that
they may bind independently of MLN51 (2). Indeed, purified,
human spliced mRNPs contained eIF4AIII, Magoh, and Y14
but not MLN51 (33). Interestingly, eIF4AIII, Magoh, and Y14,
but not Barentsz, were detected in Drosophila C complexes
(Table 1), suggesting that Barentsz (MLN51) associates inde-
pendently of the other core EJC factors at a stage after C
complex formation.
Acinus and SAP18, which in humans are components of the
EJC outer shell (53), were also detected but in all mRNP
preparations, indicating that their association with mRNA is
not necessarily dependent on splicing. Pinin could only be
identified in one preparation of spliced mRNP, indicating that
it might be lost during purification or is highly underrepre-
sented. Homologues of the human EJC-associated factor Upf2
and the non-EJC factor Upf1, which are involved in NMD,
were also identified in spliced Drosophila mRNPs; the NMD
factor Upf3, however, was detected in only one preparation
(see Table S2 in the supplemental material). Interestingly,
different from mammals, in Drosophila the presence of an EJC
is not required for NMD (17). Our data indicate that Upf1 and
Upf2 are nonetheless recruited to Drosophila mRNPs in a
splicing-dependent manner. Surprisingly, homologues of the
human EJC proteins RNSP1, Aly/REF, and UAP56 could not
be identified in any of our Drosophila mRNP preparations. The
latter two are also components of the THO/TREX complex,
which plays a role in mRNA export in humans (reviewed in
reference 42). The other TREX-associated proteins (i.e.,
THOC1, THOC2, THOC3, THOC5, and THOC7) which were
present in human mRNPs (33) were absent or highly under-
represented (based on absolute peptide numbers) in purified
Drosophila mRNPs. The apparent absence of the THO/TREX
complex in Drosophila mRNPs is consistent with previous re-
ports in which the knockdown of THO/TREX factors (with the
exception of UAP56) did not affect the export of most mRNAs
in Drosophila (44).
Our results are consistent with the idea that a stable EJC
also forms upstream of the exon-exon junction of spliced Dro-
sophila mRNPs. However, formal proof for such a complex is
still lacking. Although the results of recent pull-down experi-
ments suggest that there are differences in the splicing-depen-
dent loading of EJC factors in humans and Drosophila (60),
our results indicate that the temporal association of several
EJC proteins with the pre-mRNA is similar in both organisms.
That is, most of the known EJC proteins identified in Drosoph-
ila spliced mRNPs were first detected in C complexes, suggest-
ing that, as in humans, they associate during or subsequent to
catalytic activation. Taken together, our analyses of Drosophila
splicing complexes and spliced mRNPs suggest a remarkable
degree of conservation among metazoans at the level of their
protein composition and in terms of their compositional dy-
namics.
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